KRISTIE GRAINGER: Open Payments
NPI 1235848656 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 15 payments from 11 companies in 2025. Trend: 2023 $639 · 2024 $161 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 3 | $154 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Eisai Inc. | 2 | $46 |
| Caris MPI, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Verastem, Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: Tivdak, LYNPARZA, Lenvima, MI CANCER SEEK, Enhertu, KEYTRUDA, KISQALI, AVMAPKI FAKZYNJA CO-PACK.
Industry payments across NC — which companies pay providers there.
